Hypoxia-dependent inhibition of tumor cell susceptibility to CTL-mediated lysis involves NANOG induction in target cells

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4031-4039

  Hasmim, Meriem ^a   Noman, Muhammad Zaeem ^a   Lauriol, Jessica ^b   Benlalam, Houssem ^a   Mallavialle, Aude ^c   Rosselli, Filippo ^d   Mami Chouaib, Fathia ^a   Alcaide Loridan, Catherine ^b   Chouaib, Salem ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT JACQUES MONOD   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG;

ARTICLE; CANCER SUSCEPTIBILITY; CELL DEATH; CELL KILLING; CELL RENEWAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DNA REPLICATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; STEM CELL; TARGET CELL; TUMOR CELL; TUMOR RESISTANCE;

BLOTTING, WESTERN; CELL HYPOXIA; CELL LINE, TUMOR; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MICROSCOPY, CONFOCAL; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; TUMOR MICROENVIRONMENT;

EID: 80054769985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101011     Document Type: Article

References (45)

1. McAllister, S. S., and R. A. Weinberg. 2010. Tumor-host interactions: a far-reaching relationship. J. Clin. Oncol. 28: 4022-4028.
2. Semenza, G. L. 2010. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29: 625-634.
3. Axelson, H., E. Fredlund, M. Ovenberger, G. Landberg, and S. Påhlman. 2005. Hypoxia-induced dedifferentiation of tumor cells: a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin. Cell Dev. Biol. 16: 554-563. (Pubitemid 41247879)
4. Heddleston, J. M., Z. Li, R. E. McLendon, A. B. Hjelmeland, and J. N. Rich. 2009. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8: 3274-3284.
5. Semenza, G. L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3: 721-732. (Pubitemid 37328811)
6. Noman, M. Z., S. Buart, J. Van Pelt, C. Richon, M. Hasmim, N. Leleu, W. M. Suchorska, A. Jalil, Y. Lecluse, F. El Hage, et al. 2009. The cooperative induction of hypoxia-inducible factor-1a and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J. Immunol. 182: 3510-3521.
7. + cytolytic T cells. Cancer Res. 69: 8886-8893.
8. Niwa, H., K. Ogawa, D. Shimosato, and K. Adachi. 2009. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460: 118-122.
9. Jeter, C. R., M. Badeaux, G. Choy, D. Chandra, L. Patrawala, C. Liu, T. Calhoun-Davis, H. Zaehres, G. Q. Daley, and D. G. Tang. 2009. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27: 993-1005.
10. Bourguignon, L. Y., K. Peyrollier, W. Xia, and E. Gilad. 2008. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J. Biol. Chem. 283: 17635-17651.
11. Wu, M. J., C. I. Jan, Y. G. Tsay, Y. H. Yu, C. Y. Huang, S. C. Lin, C. J. Liu, Y. S. Chen, J. F. Lo, and C. C. Yu. 2010. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol. Cancer 9: 283.
12. Echchakir, H., I. Vergnon, G. Dorothée, D. Grunenwald, S. Chouaib, and F. Mami-Chouaib. 2000. Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung. Int. Immunol. 12: 537-546. (Pubitemid 30199359)
13. El Hage, F., V. Stroobant, I. Vergnon, J. F. Baurain, H. Echchakir, V. Lazar, S. Chouaib, P. G. Coulie, and F. Mami-Chouaib. 2008. Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway. Proc. Natl. Acad. Sci. USA 105: 10119-10124.
14. Lund, E. L., L. T. Hansen, and P. E. Kristjansen. 2005. Augmenting tumor sensitivity to topotecan by transient hypoxia. Cancer Chemother. Pharmacol. 56: 473-480. (Pubitemid 41549148)
15. Dorothée, G., H. Echchakir, B. Le Maux Chansac, I. Vergnon, F. El Hage, A. Moretta, A. Bensussan, S. Chouaib, and F. Mami-Chouaib. 2003. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma. Oncogene 22: 7192-7198. (Pubitemid 37378551)
16. Echchakir, H., F. Mami-Chouaib, I. Vergnon, J. F. Baurain, V. Karanikas, S. Chouaib, and P. G. Coulie. 2001. A point mutation in the a-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. Cancer Res. 61: 4078-4083. (Pubitemid 32720974)
17. Visvader, J. E., and G. J. Lindeman. 2008. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8: 755-768.
18. Sutherland, K. D., and A. Berns. 2010. Cell of origin of lung cancer. Mol. Oncol. 4: 397-403.
19. Eramo, A., F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, A. Di Virgilio, C. Conticello, L. Ruco, C. Peschle, and R. De Maria. 2008. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15: 504-514. (Pubitemid 351267301)
20. Jiang, F., Q. Qiu, A. Khanna, N. W. Todd, J. Deepak, L. Xing, H. Wang, Z. Liu, Y. Su, S. A. Stass, and R. L. Katz. 2009. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol. Cancer Res. 7: 330-338.
21. Mani, S. A., W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan, A. Y. Zhou, M. Brooks, F. Reinhard, C. C. Zhang, M. Shipitsin, et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715. (Pubitemid 351636299)
22. Sahlgren, C., M. V. Gustafsson, S. Jin, L. Poellinger, and U. Lendahl. 2008. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. USA 105: 6392-6397. (Pubitemid 351758356)
23. Thiery, J. P., and J. P. Sleeman. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7: 131-142. (Pubitemid 43278296)
24. Takahashi, K., and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. (Pubitemid 44233629)
25. Covello, K. L., J. Kehler, H. Yu, J. D. Gordan, A. M. Arsham, C. J. Hu, P. A. Labosky, M. C. Simon, and B. Keith. 2006. HIF-2a regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20: 557-570. (Pubitemid 43345322)
26. Gustafsson, M. V., X. Zheng, T. Pereira, K. Gradin, S. Jin, J. Lundkvist, J. L. Ruas, L. Poellinger, U. Lendahl, and M. Bondesson. 2005. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell 9: 617-628. (Pubitemid 41555144)
27. Lee, T. I., R. G. Jenner, L. A. Boyer, M. G. Guenther, S. S. Levine, R. M. Kumar, B. Chevalier, S. E. Johnstone, M. F. Cole, K. Isono, et al. 2006. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313. (Pubitemid 44313811)
28. Joseph, N. M., and S. J. Morrison. 2005. Toward an understanding of the physiological function of mammalian stem cells. Dev. Cell 9: 173-183. (Pubitemid 41051737)
29. Ohlstein, B., and A. Spradling. 2006. The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature 439: 470-474. (Pubitemid 43152837)
30. Halazonetis, T. D., V. G. Gorgoulis, and J. Bartek. 2008. An oncogene-induced DNA damage model for cancer development. Science 319: 1352-1355. (Pubitemid 351354863)
31. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
32. Buettner, R., L. B. Mora, and R. Jove. 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8: 945-954. (Pubitemid 35177340)
33. Karni, R., R. Jove, and A. Levitzki. 1999. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 18: 4654-4662. (Pubitemid 29417740)
34. Yue, H., W. Li, R. Desnoyer, and S. S. Karnik. 2010. Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. Cardiovasc. Res. 85: 90-99.
35. Forristal, C. E., K. L. Wright, N. A. Hanley, R. O. Oreffo, and F. D. Houghton. 2010. Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 139: 85-97.
36. Prasad, S. M., M. Czepiel, C. Cetinkaya, K. Smigielska, S. C. Weli, H. Lysdahl, A. Gabrielsen, K. Petersen, N. Ehlers, T. Fink, et al. 2009. Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation. Cell Prolif. 42: 63-74.
37. Kohler, E. E., C. E. Cowan, I. Chatterjee, A. B. Malik, and K. K. Wary. 2011. NANOG induction of fetal liver kinase-1 (FLK1) transcription regulate endothelial cell proliferation and angiogenesis. Blood 117: 1761-1769.
38. Li, Z., S. Bao, Q. Wu, H. Wang, C. Eyler, S. Sathornsumetee, Q. Shi, Y. Cao, J. Lathia, R. E. McLendon, et al. 2009. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15: 501-513.
39. + human glioblastoma cells in vitro. Mol. Cancer Res. 7: 489-497.
40. Ji, J., T. E. Werbowetski-Ogilvie, B. Zhong, S. H. Hong, and M. Bhatia. 2009. Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells. PLoS ONE 4: e8065.
41. Siu, M. K., E. S. Wong, H. Y. Chan, H. Y. Ngan, K. Y. Chan, and A. N. Cheung. 2008. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am. J. Pathol. 173: 1165-1172.
42. Barzilai, A., and K. Yamamoto. 2004. DNA damage responses to oxidative stress. DNA Repair (Amst.) 3: 1109-1115. (Pubitemid 38997954)
43. Schmaltz, C., P. H. Hardenbergh, A. Wells, and D. E. Fisher. 1998. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18: 2845-2854. (Pubitemid 28183453)
44. Gardner, L. B., Q. Li, M. S. Park, W. M. Flanagan, G. L. Semenza, and C. V. Dang. 2001. Hypoxia inhibits G1/S transition through regulation of p27 expression. J. Biol. Chem. 276: 7919-7926.
45. Noman, M. Z., B. Janji, B. Kaminska, K. Van Moer, S. Pierson, P. Przanowski, S. Buart, G. Berchem, P. Romero, F. Mami-Chouaib, and S. Chouaib. 2011. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T cell activity and promotes regression. Cancer Res. DOI: 10.1158/0008-5472.CAN-11- 1094.